Durrant LG - Search Results

1

Maxwell-Armstrong CA, Durrant LG, Scholefield JH. Maxwell-Armstrong CA, et al. Among authors: durrant lg. Am J Surg. 1999 Apr;177(4):344-8. doi: 10.1016/s0002-9610(99)00051-3. Am J Surg. 1999. PMID: 10326858 Review.

2

A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55.

Ullenhag GJ, Spendlove I, Watson NF, Indar AA, Dube M, Robins RA, Maxwell-Armstrong C, Scholefield JH, Durrant LG. Ullenhag GJ, et al. Among authors: durrant lg. Clin Cancer Res. 2006 Dec 15;12(24):7389-96. doi: 10.1158/1078-0432.CCR-06-1003. Epub 2006 Nov 22. Clin Cancer Res. 2006. PMID: 17121873 Clinical Trial.

3

Colorectal cancer vaccines.

Maxwell-Armstrong CA, Durrant LG, Scholefield JH. Maxwell-Armstrong CA, et al. Among authors: durrant lg. Br J Surg. 1998 Feb;85(2):149-54. doi: 10.1046/j.1365-2168.1998.00704.x. Br J Surg. 1998. PMID: 9501807 Review.

4

Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7.

Maxwell-Armstrong CA, Durrant LG, Robins RA, Galvin AM, Scholefield JH, Hardcastle JD. Maxwell-Armstrong CA, et al. Among authors: durrant lg. Gut. 1999 Oct;45(4):593-8. doi: 10.1136/gut.45.4.593. Gut. 1999. PMID: 10486371 Free PMC article. Clinical Trial.

5

A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55.

Durrant LG, Maxwell-Armstrong C, Buckley D, Amin S, Robins RA, Carmichael J, Scholefield JH. Durrant LG, et al. Clin Cancer Res. 2000 Feb;6(2):422-30. Clin Cancer Res. 2000. PMID: 10690519 Clinical Trial.

6

Vaccine-induced apoptosis: a novel clinical trial end point?

Amin S, Robins RA, Maxwell-Armstrong CA, Scholefield JH, Durrant LG. Amin S, et al. Among authors: durrant lg. Cancer Res. 2000 Jun 15;60(12):3132-6. Cancer Res. 2000. PMID: 10866299 Clinical Trial.

7

Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer.

Maxwell-Armstrong CA, Durrant LG, Buckley TJ, Scholefield JH, Robins RA, Fielding K, Monson JR, Guillou P, Calvert H, Carmichael J, Hardcastle JD. Maxwell-Armstrong CA, et al. Among authors: durrant lg. Br J Cancer. 2001 Jun 1;84(11):1443-6. doi: 10.1054/bjoc.2001.1725. Br J Cancer. 2001. PMID: 11384090 Free PMC article. Clinical Trial.

8

Current concepts in immunotherapy for the treatment of colorectal cancer.

Indar A, Maxwell-Armstrong CA, Durrant LG, Carmichael J, Scholefield JH. Indar A, et al. Among authors: durrant lg. J R Coll Surg Edinb. 2002 Apr;47(2):458-74. J R Coll Surg Edinb. 2002. PMID: 12018689 Review.

9

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

Watson NF, Ramage JM, Madjd Z, Spendlove I, Ellis IO, Scholefield JH, Durrant LG. Watson NF, et al. Among authors: durrant lg. Int J Cancer. 2006 Jan 1;118(1):6-10. doi: 10.1002/ijc.21303. Int J Cancer. 2006. PMID: 16003753

10

Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patients.

Watson NF, Madjd Z, Scrimegour D, Spendlove I, Ellis IO, Scholefield JH, Durrant LG. Watson NF, et al. Among authors: durrant lg. World J Surg Oncol. 2005 Jul 19;3:47. doi: 10.1186/1477-7819-3-47. World J Surg Oncol. 2005. PMID: 16029489 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters